Initial public offering of up to 6171102 equity shares of face value of Rs. 10/- each ("Equity Shares") of Corona Remedies Limited ("Company") for cash at a price of Rs. 1062 per equity share ("Offer Price") aggregating up to Rs. 655.37 crores ("Offer"), comprising an offer for sale of up to 1,222,598 equity shares of face value of Rs. 10/- each aggregating up to Rs. 129.84 crores by Kirtikumar Laxmidas Mehta ("Promoter Selling Sharheolder"), up to 72,1374 equity shares of face value of Rs. 10/- each aggregating up to Rs. 76.61 crores by Minaxi Kirtikumar Mehta, up to 97,834 equity shares of face value of Rs. 10/- each aggregating up to Rs. 10.39 crores by Dipabahen Niravkumar Mehta, up to 97,834 equity shares of face value of Rs. 10/- each aggregating up to Rs.10.39 crores by Brinda Ankur Mehta ("Promoter Group Selling Shareholders"), up to 3,809,792 equity shares of face value of Rs.10/- each aggregating up to Rs. 404.60 crores by Sepia Investments Limited, up to 1,42,467 equity shares of face value of Rs. 10/- each aggregating up to Rs. 15.13 crores by Anchor Partners and up to 79,284 equity shares of face value of Rs. 10/- each aggregating up to Rs. 8.42 crores by Sage Investment Trust ("Investor Selling Shareholders", and along with the promoter selling shareholder and promoter group selling shareholders, the "Selling Shareholders") ("Offer for Sale", and such equity shares offered in the offer for sale, the "Offered Shares"). The offer includes a Reservation of 55,084 equity shares of face value of Rs. 10/- each, aggregating up to Rs. 5.85 crores (Constituting up to [*] % of the post offer paid-up equity share capital of the company, for subscription by eligible employees (the "Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer shall constitute [*] % and [*] %,respectively, of the post-offer paid-up equity share capital of the company.